Gateway to Translation: Lesson learned from AI-enabled RNA-small molecule drug discovery
| Dates: | 24 September 2024 |
|---|
| Times: | 14:00 - 15:00 |
|---|
| What is it: | Webinar |
|---|
| Organiser: | Faculty of Biology, Medicine and Health |
|---|
| How much: | Free |
|---|
| Who is it for: | University staff, External researchers, Adults, Alumni, Current University students |
|---|
| Speaker: | Dr Rabia Khan, Prof Anne Willis, OBE |
|---|
|
Join us for our free online webinar, as we hear from Dr Rabia Khan on the topic of 'Lesson learned from AI-enabled RNA-small molecule drug discovery'.
Sign-up online: https://www.tickettailor.com/events/translationmanchester/1159818
The “Gateway to Translation” (G2T) webinar series is a joint initiative between the University of Cambridge (Cambridge Academy of Therapeutic Sciences, CATS) and the University of Manchester (Translation Manchester). These monthly webinars aim to stimulate the translation of research into the clinics by educating academics about trends, technologies and research in the commercial sphere and by facilitating collaborations between academia and the medtech, biotech and pharma industry sectors.
Recordings from previous webinars are available on the Translation Manchester and CATS websites.
September Webinar
This month's webinar, hosted by Cambridge Academy of Therapeutic Sciences (CATS), will be on Tuesday 24th September from 2-3pm (via Zoom). Our guest speaker will be Dr Rabia Khan, CEO of Serna Bio, who will be giving a talk on the topic of “Mapping the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small molecule drug discovery”
Rabia Khan, PhD, MBA is the founder and CEO of Serna Bio, a biotech building the world's first map of the druggable transcriptome to address novel inaccessible biology.
Before founding Serna Bio, Dr. Khan was Managing Director of Discovery Sciences at Sensyne Health Plc (now: Arcturis) where she established the scientific strategy, built the data science and discovery teams and led the pharma partnerships with Bayer, BMS, Roche and Alexion and others. She has also held senior roles at BenevolentAI and Meta (acquired by Chan Zuckerberg BioHub).
Topic: “Mapping the Druggable Transcriptome: Lesson learned from AI-enabled RNA-small molecule drug discovery”
Guest Speaker: Dr Rabia Khan (Founder and CEO of Serna Bio)
Date and Time: Tuesday 24th September, from 2-3pm (on Zoom)
Chaired by: Prof Anne Willis, OBE, OMRC Investigator and the Director of the MRC Toxicology Unit
Sign-up online: https://www.tickettailor.com/events/translationmanchester/1159818
Speakers
Dr Rabia Khan
Role: Founder and CEO
Organisation: Serna Bio
Prof Anne Willis, OBE
Role: OMRC Investigator and the Director of the MRC Toxicology Unit
Organisation: University of Cambridge
Travel and Contact Information
Find event
Online (Zoom link in sign-up confirmation)
